Literature DB >> 27940095

The epidemiology, prognosis, and trends of severe traumatic brain injury with presenting Glasgow Coma Scale of 3.

Kristin Salottolo1, Matthew Carrick2, A Stewart Levy3, Brent C Morgan4, Denetta S Slone5, David Bar-Or6.   

Abstract

PURPOSE: To characterize trends and prognosis of severe traumatic brain injury (TBI).
METHODS: This 5-year multicenter retrospective study included patients with TBI and Glasgow Coma Scale of 3. We analyzed demographic and clinical characteristics and mortality using Pearson χ2 tests, Cochran-Armitage trend tests, and stepwise logistic regression. Analyses were stratified by vehicular and fall etiologies; other etiologies were excluded (24%).
RESULTS: Included were 481 patients. Fall-related injuries increased 58% (P=.001) but vehicular etiology did not change (P=.63). The characteristics of the populations changed over time; with falls, the population became older and increasingly presented with normal vital signs, whereas with vehicular etiology, the population became younger, with more alcohol-related injury (P<.05 for all). Mortality from falls increased substantially from 25% to 63% (P<.001), whereas death from vehicular injures remained statistically unchanged but with a downward trend (50%-38%, P=.28). Predictors of mortality included injury severity and age at least 65 years for both groups. Additional variables that were prognostic were abnormal vital signs and subdural hematoma for vehicular injuries, and sex for fall injuries.
CONCLUSIONS: The epidemiology of severe TBI is changing. These epidemiologic data may be used for management and resource decisions, monitoring, and directing injury prevention measures.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Glasgow Coma Scale; Mortality; Traumatic brain injury

Mesh:

Year:  2016        PMID: 27940095     DOI: 10.1016/j.jcrc.2016.11.034

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  8 in total

1.  Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know.

Authors:  Raeesa Gupte; William Brooks; Rachel Vukas; Janet Pierce; Janna Harris
Journal:  J Neurotrauma       Date:  2019-07-19       Impact factor: 5.269

2.  Clinical efficacy and prognosis of standard large trauma craniotomy for patients with severe frontotemporal craniocerebral injury.

Authors:  Zhiqi Huang; Lijin Yan
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Prognostic properties of the association between the S-100B protein levels and the mean cerebral blood flow velocity in patients diagnosed with severe traumatic brain injury.

Authors:  Sebastian Dzierzęcki; Mirosław Ząbek; Artur Zaczyński; Ryszard Tomasiuk
Journal:  Biomed Rep       Date:  2022-05-19

4.  Physical Performance and Fall Risk in Persons With Traumatic Brain Injury.

Authors:  Dennis Klima; Lindsay Morgan; Michelle Baylor; Cordia Reilly; Daniel Gladmon; Adam Davey
Journal:  Percept Mot Skills       Date:  2018-11-20

Review 5.  Integrated Health Care Management of Moderate to Severe TBI in Older Patients-A Narrative Review.

Authors:  Rahel Schumacher; René M Müri; Bernhard Walder
Journal:  Curr Neurol Neurosci Rep       Date:  2017-10-07       Impact factor: 5.081

6.  Notch signaling inhibitor DAPT provides protection against acute craniocerebral injury.

Authors:  Hong-Mei Zhang; Pei Liu; Cheng Jiang; Xiao-Qing Jin; Rui-Ning Liu; Shun-Qing Li; Yan Zhao
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

7.  A retrospective review of patients with significant traumatic brain injury transported by emergency medical services within the south east of England.

Authors:  Jack William Barrett
Journal:  Br Paramed J       Date:  2019-03-01

8.  Incidence, causes and consequences of moderate and severe traumatic brain injury as determined by Abbreviated Injury Score in the Netherlands.

Authors:  Denise Jochems; Eveline van Rein; Menco Niemeijer; Mark van Heijl; Michael A van Es; Tanja Nijboer; Luke P H Leenen; R Marijn Houwert; Karlijn J P van Wessem
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.